Qurgen's Unattributed - II Round

Qurgen raised a round of funding on November 08, 2017.

Qurgen is a biotechnology company that has invented an innovative protein induced Pluripotent Stem Cells (piPSCs) technology that generates piPSCs from normal fibroblast and cancer cells within 1-week…

Articles about Qurgen's Unattributed - II Round: